HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Wanggang Zhang Selected Research
Wanggang Zhang Research Topics
Disease
23
Leukemia
01/2021 - 01/2004
14
Neoplasms (Cancer)
01/2021 - 03/2010
14
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2020 - 05/2005
12
Multiple Myeloma
02/2024 - 06/2012
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2020 - 02/2011
4
Acute Monocytic Leukemia (Acute Monoblastic Leukemia)
01/2021 - 05/2005
4
Residual Neoplasm
01/2020 - 02/2011
3
Carcinogenesis
01/2020 - 02/2017
2
Hematologic Neoplasms (Hematological Malignancy)
10/2023 - 10/2019
2
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
02/2020 - 09/2018
2
Aplastic Anemia (Anemia, Hypoplastic)
12/2017 - 03/2016
1
Disseminated Intravascular Coagulation
10/2023
1
Multi-centric Castleman's Disease
02/2023
1
Memory Disorders (Memory Loss)
01/2022
1
Asthma (Bronchial Asthma)
01/2022
1
Airway Remodeling
01/2022
1
Cognitive Dysfunction
01/2022
1
Hypophosphatemia
01/2021
1
Philadelphia Chromosome
01/2021
1
Pain (Aches)
01/2021
1
Blast Crisis (Blast Phase)
01/2021
1
Neutropenia
01/2021
1
Diarrhea
01/2021
1
Edema (Dropsy)
01/2021
1
Exanthema (Rash)
01/2021
1
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2021
1
Anemia
01/2021
1
Iron Overload
02/2020
1
Immune System Diseases (Immune Disorders)
01/2020
1
Autoimmune Diseases (Autoimmune Disease)
01/2020
1
Hyperthermia
10/2019
1
Lymphoma (Lymphomas)
10/2019
1
Respiratory Insufficiency (Respiratory Failure)
10/2019
1
Shock
10/2019
1
Disease Progression
01/2019
1
Neurodegenerative Diseases (Neurodegenerative Disease)
01/2019
1
Atherosclerosis
12/2018
1
Cardiovascular Diseases (Cardiovascular Disease)
12/2018
1
Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
02/2018
Drug/Important Bio-Agent (IBA)
12
Antigens
IBA
01/2021 - 05/2005
7
Proteins (Proteins, Gene)
FDA Link
01/2022 - 05/2008
5
MicroRNAs (MicroRNA)
IBA
01/2022 - 11/2016
4
Peptides (Polypeptides)
IBA
01/2021 - 01/2013
4
Epitopes
IBA
01/2021 - 05/2005
4
Biomarkers (Surrogate Marker)
IBA
01/2020 - 06/2012
3
Chimeric Antigen Receptors
IBA
02/2024 - 10/2019
3
HLA-A*02:01 antigen
IBA
01/2021 - 12/2014
3
Long Noncoding RNA
IBA
06/2020 - 10/2017
3
Vaccines
IBA
01/2019 - 09/2012
3
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
11/2018 - 04/2017
3
Complementary DNA (cDNA)
IBA
06/2017 - 01/2004
3
Messenger RNA (mRNA)
IBA
11/2016 - 05/2008
2
B-Cell Maturation Antigen
IBA
02/2024 - 10/2023
2
Immunologic Adjuvants (Immunologic Adjuvant)
IBA
01/2021 - 02/2011
2
Cytokines
IBA
01/2021 - 11/2016
2
Therapeutic Uses
IBA
01/2021 - 12/2010
2
Iron
IBA
02/2020 - 05/2017
2
DNA (Deoxyribonucleic Acid)
IBA
01/2019 - 05/2005
2
thymoglobulin
FDA Link
12/2017 - 03/2016
2
Catenins
IBA
01/2017 - 01/2015
2
Cancer Vaccines
IBA
09/2012 - 02/2011
1
bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amine
IBA
02/2024
1
Dacarbazine (DIC)
FDA Link
Generic
10/2023
1
Mycophenolic Acid (Cellcept)
FDA Link
Generic
02/2023
1
Methylprednisolone
FDA Link
Generic
02/2023
1
Immunosuppressive Agents (Immunosuppressants)
IBA
02/2023
1
pyrazolanthrone
IBA
01/2022
1
isorhapontigenin
IBA
01/2022
1
CCCTC-Binding Factor
IBA
01/2022
1
Acetylcholine (Acetylcholine Chloride)
FDA Link
01/2022
1
Acetylcholinesterase
IBA
01/2022
1
JNK Mitogen-Activated Protein Kinases
IBA
01/2022
1
flumatinib
IBA
01/2021
1
Protein Subunit Vaccines
IBA
01/2021
1
Imatinib Mesylate (Gleevec)
FDA Link
01/2021
1
Alanine Transaminase (SGPT)
IBA
01/2021
1
Caspase 3 (Caspase-3)
IBA
01/2020
1
Factor X (Stuart Factor)
IBA
01/2020
1
Thalidomide (Thalomid)
FDA Link
12/2019
1
Platelet Factor 4
IBA
12/2019
1
tocilizumab (atlizumab)
FDA Link
10/2019
1
Interleukin-17 (Interleukin 17)
IBA
06/2019
1
Nicotinamide Phosphoribosyltransferase
IBA
06/2019
1
RNA (Ribonucleic Acid)
IBA
01/2019
1
Ribonuclease P (RNase P)
IBA
01/2019
1
oxidized low density lipoprotein
IBA
12/2018
1
Endothelins (Endothelin)
IBA
12/2018
1
Aclarubicin
IBA
09/2018
1
Cytarabine (Cytosar-U)
FDA Link
Generic
09/2018
1
Cell Surface Receptors
IBA
01/2018
1
fluorine monoxide
IBA
01/2018
1
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2018
Therapy/Procedure
11
Immunotherapy
01/2021 - 05/2005
8
Therapeutics
02/2024 - 03/2010
5
Drug Therapy (Chemotherapy)
11/2018 - 01/2013
3
Induction Chemotherapy
01/2019 - 01/2016
2
Salvage Therapy
02/2024 - 11/2018
1
Aftercare (After-Treatment)
01/2021
1
Chelation Therapy (Therapy, Chelation)
02/2020
1
Blood Transfusion (Blood Transfusions)
02/2020